Close Menu

NEW YORK (GenomeWeb) – Aperiomics has been awarded additional Small Business Innovative Research funding from the National Science Foundation, the firm announced today.

The funding, which totals $229,000, will support the further development of the firm's deep metagenomic shotgun sequencing-based test that can be used to identify infectious disease pathogens. The test detects all bacteria, DNA viruses, fungi, and parasites in a single sample, comparing sequencing results to the firm's proprietary database of more than 32,000 microorganism genomes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
14

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.